Ipharma Tirzepatide Vial 30mg | High-Purity Compound Research Peptide

Ipharma Tirzepatide 30mg is a premium research-grade peptide designed for advanced metabolic studies. As a potent dual agonist, this compound interacts with both the Glucose-dependent Insulinotropic Polypeptide (GIP) and Glucagon-like Peptide-1 (GLP-1) receptors. This unique profile allows researchers to investigate sophisticated pathways involving metabolic regulation, glucose homeostasis, and systemic energy signaling in controlled laboratory environments.

Key Features & Benefits:

Dual-Agonist Research: Engineered to facilitate the study of synergistic GIP and GLP-1 receptor activity in metabolic pathways.

Metabolic Signaling Study: A critical tool for researchers focused on insulin sensitivity, glucose metabolism, and hormonal feedback loops.

Energy Homeostasis: Widely utilized in research models exploring appetite regulation mechanisms and long-term energy storage dynamics.

High-Purity Standards: Manufactured under stringent quality control protocols to ensure the high levels of consistency and purity required for precise, reproducible scientific results.

Optimized Concentration: Provided in a 30mg vial, offering a convenient and reliable supply for longitudinal laboratory applications.

⚖️ DISCLAIMER This product is intended strictly for laboratory research purposes only. It is not a medicine and has not been evaluated or approved by the South African Health Products Regulatory Authority (SAHPRA) for human or animal use. This product is not intended for human consumption and may not be used to diagnose, treat, cure, or prevent any disease. By purchasing, the customer confirms they are legally permitted to handle and use this product in accordance with applicable laws and regulations.

Shipping Notice: All orders are processed and dispatched within 24 to 48 hours of payment confirmation. Once dispatched, you will receive a tracking notification via email.